US Patent 8138344 Process for the preparation of rapamycin derivatives
Patent 8138344 was granted and assigned to Novartis on March, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+368 characters)
Article
Patent abstract
Processes for the production of a 32-deoxorapamycin from a 32-iodo- or 32-hydroxyrapamycin, wherein the hydroxy group is substituted by the residue of an arylthionocarbonate or an arylthiocarbamate, in the presence of tris(trimethylsilyl)-silan and α,α′-azo-isobutyronitril in organic solvent; and 32-deoxorapamycin in the form of a crystalline solvate.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08138344 Process for the preparation of rapamycin derivatives US Patent 8138344 Process for the preparation of rapamycin derivatives
Infobox
Patent Number
0813834400
Patent Number
813834400
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081383440
Date of Patent
March 20, 2012
0Patent Application Number
121601100
Date Filed
January 22, 2007
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081383440
Date of Patent
March 20, 2012
0Patent Application Number
121601100
Date Filed
January 22, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08138344 Process for the preparation of rapamycin derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08138344
Date of patent
March 20, 2012
Patent application number
12160110
Date Filed
January 22, 2007
Patent primary examiner
Find more entities like US Patent 8138344 Process for the preparation of rapamycin derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
